Subiradi Tablet
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
MFDS item code 201903718 · Approved 2019.06.04
This product's status changed to Approval withdrawn on 2024.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (including ulcers) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome
This medication is used for gastric and duodenal ulcers, gastritis, and conditions related to excessive gastric acid secretion such as Zollinger-Ellison syndrome. It is also effective in treating gastroesophageal reflux and helps prevent Mendelson's syndrome when administered before anesthesia. It is used to prevent and treat ulcers that may occur postoperatively and gastric/duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication is effective in improving various gastrointestinal diseases.
○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to combination therapy for preventing gastric or duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. The dose may be increased to 2 tablets four times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet three times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is also preferable to administer 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis or those with severely impaired kidney function. Patients who have had an allergic reaction to this medication or its components should also avoid it. Patients who have had a rare disease called acute porphyria should exercise caution as this medication may exacerbate symptoms. It is best not to use this medication in patients who have undergone gastrointestinal surgery, are pregnant or may become pregnant, and in premature infants or newborns. Patients who need to restrict potassium intake should also avoid this medication. Patients with liver impairment, a history of drug allergies, elderly patients, and those who have had kidney issues should use this medication with caution. If taken together with non-steroidal anti-inflammatory drugs, there may be an increased risk of gastrointestinal bleeding, necessitating regular tests. This medication may mask symptoms of gastric cancer; therefore, patients over middle age with a newly occurring or changing dyspepsia should verify the absence of malignancy before use. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should also receive eradicating therapy. Patients in severe intensive care may be at risk for gastric stones, hence caution is necessary. Patients with low phosphate levels should be careful as the aluminum content in this medication may hinder phosphate absorption. Patients who have difficulty swallowing may experience respiratory complications after taking this medication, thus caution is advised. While taking this medication, severe allergic reactions, skin rashes, blood disorders, liver dysfunction, cardiac arrhythmias, digestive disorders, and neurological abnormalities may occur rarely. If such symptoms appear, consult a doctor immediately and stop taking the medication. Long-term use of this medication should be avoided, and if there is no therapeutic effect, it should be changed to another medication. Regular blood tests, liver function tests, and kidney function tests are required. Elderly patients or those with chronic lung diseases, diabetes, or weakened immune systems may be at an increased risk of pneumonia while on this medication, thus caution is necessary. If dizziness or drowsiness occurs after taking, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so inform your doctor or pharmacist of any other medications you are taking. Special caution is needed when taken with some antibiotics, anticonvulsants, anticoagulants, etc. It is safest for pregnant or breastfeeding women to avoid using this medication. Safety and efficacy in children have not been sufficiently documented, so its use is not recommended. In case of overdose, emergency measures such as vomiting or gastric lavage may be needed, and in certain cases, blood dialysis may be beneficial. This medication reduces gastric acid secretion, which may promote bacterial proliferation in the gastrointestinal tract, so regular check-ups including ophthalmological exams are necessary during prolonged use.
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius.
Greenish rectangular film-coated tablet
10 tablets - 10 tablets/bottle, 30 tablets - 30 tablets/bottle, 300 tablets - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.